ELH-IVFExogenous Luteinizing Hormone for Improving Embryo Quality in IVF with Excessive LH Suppression

This study focuses on finding ways to improve embryo quality for women undergoing in vitro fertilization (IVF) who experience excessive suppression of a hormone called luteinizing hormone (LH) during their treatment. LH is important for the final stages of egg development and ovulation, and when its levels are too low during IVF, it may negatively affect the quality of embryos. The study specifically targets women who meet certain criteria for low LH levels before or during their IVF stimulation process. The goal is to determine if adding extra LH to their treatment can enhance embryo quality, potentially leading to better pregnancy outcomes. Participants in the study are randomly divided into two groups. One group receives the usual ovarian stimulation treatment without any changes, while the other group gets additional LH along with their standard treatment. The study will compare the number of high-quality embryos produced in each group. Researchers will also look at other outcomes like pregnancy rates, the success of embryo implantation, live birth rates, and monitor any safety concerns such as the development of ovarian hyperstimulation syndrome (OHSS). By gathering this information, the study aims to improve IVF protocols and help women achieve better reproductive results.